People
BioSpace spoke with four veterans in the field about the less obvious reasons why companies with good science may still fail.
Biopharma and life sciences organizations strengthen their leadership teams and boards with these Movers & Shakers.
While the president temporarily shores up leadership at the OSTP, the NIH is losing another long-time career researcher, John R. Mascola.
95% of those surveyed agreed that the pandemic showed the vulnerabilities of the medicine supply chain.
After a filibuster was broken Monday, the Senate confirmed Califf’s nomination in a 50-46 bipartisan vote.
Kallyope focuses on the gut-brain axis, a bi-directional communication between the gastrointestinal tract and the brain.
Robert Califf’s nomination to resume his role as FDA Commissioner continues to advance in the Senate, despite some opposition from a key Democrat, Sen. Joe Manchin.
With EVADER, the Chameleon team hopes to make one-and-done treatments a relic of the past.
Exo Therapeutics’ approach is not only different, it has revolutionary potential.
Well into the new year, biopharma and life sciences companies bolster their executive leadership teams and boards with these Movers & Shakers.
PRESS RELEASES